SL Science Holding Limited (NasdaqGM: SLBT)
Health Care · Biotechnology · TW
$2.66
-0.37% today · -74.1% 1Y
SL Science Holding Limited (NasdaqGM: SLBT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $429.92M and employs 15 people.
Over the last twelve months the share price has lost 74.1%, trading between 2.54 and 14.50.
Tweenvest scores SL Science Holding Limited across four factors: value 63/100. Its strongest factor is value.
SLBT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $429.92M
- Revenue (TTM)
- $3.27M
- P/E
- —
- EPS
- -0.64
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $14.50
- 52-week low
- $2.54
- Avg volume (3M)
- —
- Shares outstanding
- 161.63M
- Employees
- 15
- Next earnings
- —
About SL Science Holding Limited
Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization. The firm was founded in 2023 and maintains its headquarters in New York, New York.
- ISIN
- KYG8191L1169
- Listed since
- Feb 5, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.09 | -0.01% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $65.40B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $59.75B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.